Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Conference News

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

Todd Neale

November 16, 2021

News Conference News AHA 2018

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

Yael L. Maxwell

November 12, 2018

News Daily News

Preclinical Study Casts Doubt on Regenerative Ability of Special Cardiac Stem Cells

May 12, 2014

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Conference News AHA 2013

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

November 17, 2013

Presentation

Clinical Outcomes and Surrogate Efficacy Data for a Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients with Ischemic or Nonischemic Chronic Heart Failure

Presenter: Emerson C. Perin

January 27, 2013

News Conference News Cell Therapy 2013

Small Heart Failure Studies Show Positive Trends for Cell Therapy

January 27, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Presenter: Kenneth M. Borow

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Presenter: Kenneth Borow

January 22, 2013

Presentation TCT 2012

AMICI: Use of Mesenchymal Precursor Cells in the Treatment of STEMI Patients (FIM/IIB Study)

Presenter: Henricus Duckers

October 22, 2012

Advertisement

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

Preclinical Study Casts Doubt on Regenerative Ability of Special Cardiac Stem Cells

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

Clinical Outcomes and Surrogate Efficacy Data for a Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients with Ischemic or Nonischemic Chronic Heart Failure

Small Heart Failure Studies Show Positive Trends for Cell Therapy

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

AMICI: Use of Mesenchymal Precursor Cells in the Treatment of STEMI Patients (FIM/IIB Study)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content